PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.39%
Revenue growth above 1.5x WEED.TO's 10.68%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
6.16%
Gross profit growth under 50% of WEED.TO's 45.98%. Michael Burry would be concerned about a severe competitive disadvantage.
-39.85%
Negative EBIT growth while WEED.TO is at 72.95%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-39.85%
Negative operating income growth while WEED.TO is at 72.95%. Joel Greenblatt would press for urgent turnaround measures.
2.92%
Net income growth under 50% of WEED.TO's 69.06%. Michael Burry would suspect the firm is falling well behind a key competitor.
-2.20%
Negative EPS growth while WEED.TO is at 69.70%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2.20%
Negative diluted EPS growth while WEED.TO is at 69.70%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
29.60%
Share count expansion well above WEED.TO's 2.04%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
23.80%
Diluted share count expanding well above WEED.TO's 2.04%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-62.19%
Negative OCF growth while WEED.TO is at 15.43%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
32.43%
Positive FCF growth while WEED.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.89%
Negative 10Y OCF/share CAGR while WEED.TO stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-90.89%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
336.85%
Positive 3Y OCF/share CAGR while WEED.TO is negative. John Neff might see a big short-term edge in operational efficiency.
228.97%
10Y net income/share CAGR of 228.97% while WEED.TO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
228.97%
5Y net income/share CAGR above 1.5x WEED.TO's 61.71%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
879.72%
3Y net income/share CAGR above 1.5x WEED.TO's 86.53%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
539.94%
Equity/share CAGR of 539.94% while WEED.TO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
539.94%
5Y equity/share CAGR at 75-90% of WEED.TO's 688.46%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
1391.78%
3Y equity/share CAGR above 1.5x WEED.TO's 616.31%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.51%
AR growth well above WEED.TO's 4.64%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.64%
Inventory shrinking or stable vs. WEED.TO's 12.64%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
63.87%
Asset growth above 1.5x WEED.TO's 7.40%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
33.53%
BV/share growth above 1.5x WEED.TO's 4.99%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-4.80%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-65.35%
Our R&D shrinks while WEED.TO invests at 271.43%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
26.25%
SG&A growth well above WEED.TO's 28.86%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.